You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

 

Online download statistics by month:

Online download statistics by month: October 2021 to February 2026

AbstractFullPdf
Oct 2021812820312
Nov 202133333488
Dec 202120020077
Jan 202216416892
Feb 202213413669
Mar 202213113754
Apr 202217718581
May 202212012469
Jun 202221122077
Jul 202219119565
Aug 202223123378
Sep 2022199206252
Oct 2022221226109
Nov 202215615683
Dec 2022909050
Jan 2023929453
Feb 202315515549
Mar 202311711861
Apr 2023808173
May 2023727243
Jun 2023919148
Jul 2023777745
Aug 202314915048
Sep 2023767637
Oct 202310210250
Nov 202319319356
Dec 202311711844
Jan 2024959731
Feb 2024727234
Mar 202410510757
Apr 2024697049
May 2024606237
Jun 2024575742
Jul 2024747553
Aug 2024656443
Sep 20246268219
Oct 2024565943
Nov 2024707150
Dec 2024656629
Jan 2025727238
Feb 202514614978
Mar 2025757554
Apr 202513213274
May 20259810078
Jun 2025636453
Jul 2025110
Feb 2026110
Total612962193225